baber/WOPTO huggingface dataset:
Patent NZ-566542-A (NZ)
Title: Sachet formulation for amine polymers
Inventor: BHAGAT HITESH R
IPC: A61K9/00
Filed: 2006-09-12
Abstract: Disclosed is a container containing a powder, the powder comprising a mixture of: a) a pharmaceutically acceptable anionic stabilizer comprising an esterified alginate; b) carbonate salt of sevelamer mixed with the anionic stabilizer, wherein the amount of the sevelamer carbonate is 800 mg on an anhydrous basis; and wherein the container is a sachet and the ratio of the anionic stabilizer to sevelamer carbonate is 0.005-1:1. Also disclosed is the use of said powder in the treatment of hyperphosphatemia.
Patent NZ-570531-A (NZ)
Title: Medication management and event logger analysis system
IPC: G06F19/00
Filed: 2004-01-09
Abstract: A system for use with a medication administration device for reducing the possibility of medication errors comprises a first program loaded onto a computer; a second program loaded onto a computer in a medication administration device; communication means for communicating the indication that the programmed operating parameter is outside the limits of the second database to an event log database; and means for consolidating and analyzing information and reporting results of the analysis to identify patterns and frequency of logged events. The first program is configured to accept user inputs related to a medication administration device operating parameters limits and to generate a data base from those user inputs. The second program is configured to receive the medication administration device parameter data base generated by the first program. The second program is also configured to compare medication device parameters programmed into the medication administration device by an operator with a second data base of institutionally accepted guidelines, and the second program is also configured to monitor the comparison and, if the comparison exceeds the limits established in the second data base, to provide an indication to the medication administration device operator that the programmed operating parameter is outside the limits in the second data base.
Patent NZ-572814-A (NZ)
Title: Vacuum skin packaging apparatus and process
Inventor: GRANILI ANDREA
IPC: B23K26/40
Filed: 2007-05-28
Abstract: A vacuum skin packaging apparatus for vacuum skin packaging products and obtaining packets by a single skin cycle is disclosed. The apparatus includes: a loading station where the products to be packaged are suitably spaced on a bottom thermoplastic web; a skin station where (i) a top thermoplastic web is positioned above the products, (ii) the top thermoplastic web is heated, (iii) a vacuum between the top thermoplastic web and the bottom thermoplastic web is applied and (iv) the top thermoplastic web is drawn over and all around the products thus sealing wherever the two webs contact each other; and a cutting station where the packaged products are separated by cutting the superimposed and sealed webs. The cutting station contains a cutting device which comprises a laser source (LS) producing a laser beam (LB) and means for directing (MR) the laser beam towards the area where the two webs contact each other. The reflected laser beam follows a predetermined path so that the two webs become cut and the products become packaged singularly.
Patent NZ-578955-A (NZ)
Title: Use of il-23 antagonists for treatment of aspergillosis
Inventor: KOPF MANFRED
IPC: C07K16/24
Filed: 2008-02-08
Abstract: The use of an antagonist of interleukin-23 (IL-23) for the treatment of a chronic fungal infection that is aspergillosis. The antagonist can be an antibody that specifically binds to IL-23p19, an antibody that specifically binds IL-23R, a soluble receptor derived from the extracellular region of IL-23R, an antisense nucleic acid directed to IL-23p19, an siRNA directed to IL-23p19, and antisense nucleic acid directed to IL-23R, or and siRNA directed to IL-23R.
Patent NZ-581004-A (NZ)
Title: Method of increasing methane production from a geological formation by introducing yeast additives into the formation
Inventor: PFEIFFER ROBERT S
IPC: E21B43/22
Filed: 2008-06-17
Abstract: Disclosed is a method of stimulating biogenic production of methane, the method comprising: accessing a consortium of microorganisms in a first geologic formation that includes a carbonaceous material; and providing an amendment to the microorganisms consisting exclusively of a yeast extract amendment, wherein the yeast extract amendment comprises one or more components selected from the group consisting of blood meal, fish meal. meat and bone meal, beef peptone, products of barley, products of beet, products of corn, products of cottonseed, products of potato, products of wheat, products of oat, and products of soybean, and wherein the yeast extract amendment stimulates the consortium to metabolise the carbonaceous material into the methane.
Patent NZ-581268-A (NZ)
Title: Flotation device with an outer garment and an inner inflatable bladder having neck and chest regions
Inventor: WITHERS MAREE
IPC: A41D13/012
Filed: 2009-11-18
Abstract: A flotation device is disclosed which comprises an outer garment having an inner lining located adjacent an inner surface of the outer garment and attached thereto, and an inflatable bladder encapsulated within the inner lining. The inflatable bladder comprises a neck region and at least one hest region. The neck region comprises a first outer surface and a second outer surface, where the first outer surface, in use, is located adjacent a wearer's body. When the inflatable bladder is inflated, at least one raised support chamber having an outer chamber surface at its upper extent, is disposed on the second outer surface such that the distance between the outer chamber surface and the first outer surface is greater than the distance between the second outer surface and the first outer surface.
Patent NZ-582395-A (NZ)
Title: Syringe with a detachable catheter cap integrated into the plunger containing an antiseptic absorbent material
Inventor: ANDERSON WILLIAM
IPC: A61M39/20
Filed: 2008-06-23
Abstract: Disclosed is an antiseptic cap of a flexible material having an annular shape for use with an access device to reduce commination. The cap comprises a housing having an annular sidewall defining an antiseptic fluid chamber, the housing having opposed first and second ends with an end wall closing the first end, the sidewall having an inner surface with threads extending along a portion of the inner surface. A thread cover to prevent ingress of contaminants into the chamber and retain the antiseptic fluid, is at the second end of the housing, the thread cover creating a physical barrier seal between the chamber and outside the chamber when the housing is attached to, and the thread cover contacts, an access device. The thread cover extends out from the second end of the housing and radially inward over a portion of the chamber.
Patent NZ-587182-A (NZ)
Title: Cannula base to which a delivery part and an injection part can be connected
Inventor: GYRN STEFFEN
IPC: A61M5/158
Filed: 2009-02-12
Abstract: A fluid connection (60) having at least a first and a second opening (at 17, 18), i.e. an inlet and an outlet, where the first opening forms a fluid connection to a medication supply and the second opening forms a fluid connection to an opening in the body of a separate cannula part and an at least partly sub- or transcutaneous positioned cannula (22). The fluid connection is characterized in that is attached to a surface plate (1) and has the form of a tube made of a rigid material. A base part comprising such a fluid connection is also disclosed.
Patent NZ-589254-A (NZ)
Title: Specific stabilizing strip for safety cones
Inventor: SWEENEY CHERIE KURARANGI
IPC: E01F9/627
Filed: 2010-11-15
Abstract: 589254 A flexible connecting strip for joining together and stabilizing road safety cones, comprising a flat strip with an opening at either end.
Patent NZ-598405-A (NZ)
Title: Prepolymers suitable for making ultra-violet absorbing contact lenses
Inventor: DOMSCHKE ANGELIKA MARIA
IPC: C08F30/08
Filed: 2010-09-13
Abstract: 598405 Disclosed is an actinically crosslinkable prepolymer, comprising: in the branched copolymer chains of the prepolymer, (1) crosslinking polysiloxane polymeric units derived from at least one polysiloxanecontaining crosslinker; (2) hydrophilic polymeric units derived from one or more hydrophilic vinylic monomers; (3) dual photofunctional polymeric unit, wherein the dual photo-functional polymeric units are derived from a polymerizable compound having a photoinitiating moiety and a UV-absorbing or latent UV-absorbing moiety; (4) optionally dangling polysiloxane polymeric units derived from one or more monoethylenically functionalized polysiloxane-containing vinylic monomers or macromers, wherein the dangling polysiloxane units is free of ethylenically unsaturated group; and (5) optionally siloxane polymeric units derived from at least one siloxane-containing vinylic monomer, wherein the prepolymer comprises three or more ethylenically unsaturated groups and is soluble in a solvent to form a solution and capable of being actinically crosslinked, in the absence of one or more vinylic monomers or a crosslinking agent, to form a UV absorbing or blocking silicone hydrogel contact lens.
Patent NZ-599876-A (NZ)
Title: Radio frequency identification reader antenna having a dynamically adjustable q-factor
Inventor: BATEMAN LEIGH
IPC: G06K7/00
Filed: 2010-10-11
Abstract: 599876 Disclosed is a reader circuit for a radio frequency identification (RFID) reader having a dynamically adjustable Q-factor such that the reader transmits an activation signal configured to activate half duplex and full duplex transponders. The reader circuit has a signal source (611) configured to drive a resonant antenna (614), and a dynamic switching circuit configured to set the Q-factor of the resonant antenna (614) to a first value during the transmission of the activation signal. The resonant antenna (614) is a multi-filar antenna (614) comprising a primary filar (614a) and a set of secondary filars (614b) and a resistor (619) that is connected in series with at least one of the filars (614a, 614b). The dynamic switching circuit is configured to set the Q-factor of the resonant antenna (614) to a second value below the first value during detection of a data signal from a full duplex transponder. The dynamic switching circuit is also configured to set the Q-factor of the resonant antenna (614) to a third value below the second value when the RFID reader is not transmitting the activation signal. The dynamic switching circuit is also configured to control the Q-factor of the multi-filar resonant antenna (614). This is achieved by controlling the filars (614a, 614b) that are incorporated into the resonant antenna (614) circuit by setting the Q-factor of the resonant antenna (614) at a first value during the transmission of an activation signal comprises incorporating at least two of the filars into the resonant antenna (614) circuit so that the resistor (619) is not incorporated within the resonant antenna (614) circuit. The Q-factor of the resonant antenna (614) is then decreased during receipt of a data signal from any full duplex transponders present and during the transmission of the activation signal comprises incorporating a primary filar (614a) into the resonant antenna (614) circuit so that the resistor (619) is not incorporated in the resonant antenna (614) circuit. Finally, the Q-factor of the resonant antenna (614) is decreased upon stopping the transmission of the activation signal comprises incorporating the primary filar and the resistor (619) into the resonant antenna (614) circuit.
Patent NZ-600955-A (NZ)
Title: Levitating disk
Inventor: Yigal Mesika
IPC: A63J21/00
Filed: 2011-01-17
Abstract: A lightweight conjurer’s or magician’s spinning levitating disk 100 to be suspended and spun on an “invisible” thread, includes a disk shaped housing 102 with a central axis and a series of LEDs 104 on the housing, and a circuit board 304 attached to and within the housing and connected to the LEDs. The board includes a central portion and a plurality of arms. A battery 306 is mounted on the outer end of each arm and connected to the circuit board to power the LEDs. The disk is thereby substantially equally weighted around the central axis. A “micro-thread” can be attached using an adhesive to the top of the disk on the central axis. By arranging the batteries around near the periphery of the disk, the rotational inertia of the disk can be increased to ensure stable rotation of the disk without an increase of the overall weight of the disk. The user can spin the disk about the central axis whilst the disk is suspended by the micro-thread to cause the lights (LEDs) to illuminate and to cause the disk to appear as if it is levitating.
Patent NZ-601639-A (NZ)
Title: Method and system for conducting legal research using clustering analytics
Inventor: BAYLISS DAVID
IPC: G06F17/00
Filed: 2011-01-28
Abstract: Disclosed is a system for conducting legal research using clustering analytics. The system includes a processor, a user interface configured to receive search input representing a search query, a definition generator configured to generate at least one search definition based on the search input and a clustering module. The clustering module identifies, based on the at least one search definition, query-based search results including two or more passages ranked by relevance to the search query, each passage corresponding to a respective case law document. Relationship information is determined between a subset of passages from the two or more of passages based on one or more attributes of passages from the subset of passages, including a first passage associated with a first case law document and having a highest relevance ranking of the subset of passages. All of the one or more attributes are identified by a computer. A plurality of sub-clusters are then determined by clustering the subset of passages based on the relationship information using multiple clustering spaces and combining the results, or a combination thereof. Finally, one or more additional passages are identified from the subset of passages based on the one or more additional passages being in a same sub-cluster as the first passage.
Patent NZ-603948-A (NZ)
Title: A helmet and method of manufacturing a helmet to absorb radial and tangential forces comprising an energy absorbing layer and sliding facilitators
Inventor: HALLDIN PETER
IPC: A42B3/06
Filed: 2011-05-03
Abstract: 603948 Disclosed is a helmet suitable for activities such as cycling or skiing and a method of manufacturing a helmet. The helmet comprises an outer shell (1); an attachment device (3); an energy absorbing layer (2) and sliding facilitators (5). The energy absorbing layer (2) functions to absorb oblique impact which involves radial and tangential forces acting simultaneously. The attachment device (2) is designed to fit a wearer's head. The energy absorbing layer (2) is adapted to absorb energy from an impact on the helmet by compression of the energy absorbing layer (2). Either a sliding facilitator (5) is provided inside the energy absorbing layer (2) in relation to the attachment device (3) and slides in response to a rotational force created by an oblique impact on the helmet. Alternatively, a sliding facilitator (5) is fixed to the attachment device (3) and another sliding facilitator (5) is fixed to the energy absorbing layer (3). The sliding facilitators (5) are adapted to slide against each other in response to a rotational force created by an oblique impact.
Patent NZ-611429-A (NZ)
Title: Gpr120 receptor agonists and uses thereof
Inventor: SHI DONG FANG
IPC: C07D407/04
Filed: 2009-12-17
Abstract: Disclosed herein are fused bicyclic compounds of general formula (A), wherein the substituents are as defined within the specification, processes for their preparation, compositions comprising said compounds and uses thereof. Said compounds are useful as GPR120 agonists (gastrin releasing peptide), as such are useful in the treatment of metabolic diseases associated with poor glycemic control such as Type I or II diabetes and metabolic syndrome.
Patent NZ-612719-A (NZ)
Title: Combination of acylated glucagon analogues with insulin analogues
Inventor: FOSGERAU KELD
IPC: A61P3/10
Filed: 2012-01-20
Abstract: Disclosed is a use a compound having the formula: R1-Z-R2; wherein the formulae represented by R1, Z and R2 are as defined in the specification; in the manufacture of a medicament for preventing or reducing weight gain or promoting weight loss in a mammalian subject having type 2 diabetes that is receiving an insulin analogue.
Patent NZ-623915-A (NZ)
Title: Antigen presenting cancer vaccine with gamma interferon
Inventor: CORNFORTH ANDREW
IPC: A61P35/00
Filed: 2012-10-22
Abstract: Disclosed is a melanoma vaccine comprising: at least one dendritic cell from a subject that has melanoma, wherein the at least one dendritic cell has been contacted in vitro with at least one melanoma tumour cell from the same subject, wherein the melanoma tumour cell has been treated in vitro with interferon-gamma (IFN-gamma) or with an IFN-gamma mimetic, and further wherein the at least one melanoma tumour cell is non-dividing, autophagic, and non-apoptotic. Also disclosed is the use of the above-described melanoma vaccine in the manufacture of a medicament for stimulating an immune response against a melanoma-specific antigen in a subject with melanoma.
Patent NZ-625447-A (NZ)
Title: Thienopyrimidine inhibitors of atypical protein kinase c
Inventor: DORSEY BRUCE D
IPC: C07D495/14
Filed: 2012-11-19
Abstract: The present disclosure provides a compound of formula (I) or a salt thereof, wherein R1, R2, R3, R4, R5, R6, A, G, M, Q and X are as defined herein. A compound of formula (I) and its salts have a PKC inhibitory activity, and may be used to treat proliferative disorders such as cancer. Examples of compounds of formula (I) are: (S)-3-Phenyl-N*1*-(2-pyridin-4-yl-7-[1,2,3]triazol-1-yl-thieno[3,2-d]pyrimidin-4-yl)-propane-1,2-diamine; (S)-N*1*-[7-(2-Cyclopropyl-ethyl)-2-pyridin-4-yl-thieno[3,2-d]pyrimidin-4-yl]-3-phenyl-propane-1,2-diamine; (E)-3-[4-((S)-2-Amino-3-phenyl-propylamino )-2-pyridin-4-yl-thieno[3,2-d]pyrimidin-7-yl]-acrylic acid tert-butyl ester and 4-((S)-2-Amino-3-phenyl-propylamino)-2-pyridin-4-yl-thieno[3,2-d]pyrimidine-7-carboxylic acid dimethyl amide.
Patent NZ-701647-A (NZ)
Title: Compounds and methods for antiviral treatment
Inventor: HUI HON CHUNG
IPC: C07D519/00
Filed: 2013-04-17
Abstract: Compounds and pharmaceutically acceptable salts and esters and compositions thereof, for treating viral infections are provided. The compounds and compositions are useful for treating Pneumovirinae virus infections. The compounds, compositions, and methods provided are particularly useful for the treatment of Human respiratory syncytial virus infections.
Patent NZ-707368-A (NZ)
Title: Composition and use of hydrogenated alkyl ketene dimers
Inventor: BRUNGARDT CLEMENT
IPC: D21H19/46
Filed: 2013-10-23
Abstract: Latent dispersants were made by the hydrogenation of an alkyl ketene dimer, alkenyl ketene dimer, or ketene multimer. Adding the latent dispersant to paper or paperboard increased its resistance to water and water vapor while maintaining recyclability and repulpability. Additionally, provided is a method for increasing the repulpability of a wax coated paper or paperboard. Dispersants made by the hydrolysis of the alkyl ketene dimer, alkenyl ketene dimer, and ketene multimer are also described.
Patent NZ-713120-A (NZ)
Title: Dye mixtures of reactive dyes, production and use
Inventor: BARBIERU ROXANA
IPC: C09D11/328
Filed: 2014-08-27
Abstract: The present invention is directed to dye mixture(s) comprising at least one dye of general formula (I) and at least one dye selected from the group consisting of the dyes of formula (IIa)-(IIf) process for their production and their use for dying fibers and textiles.
Patent NZ-717408-A (NZ)
Title: Hair styling apparatus
Inventor: LEUNG ANTHONY KIT LUN
IPC: A45D7/02
Filed: 2016-02-24
Abstract: A new hair treatment or styling apparatus is disclosed. Embodiments of the apparatus are adapted to impart a straightening and/or curling effect on hair and include both a novel thermally conductive construction and heating assembly, which conveys thermal energy uniformly to all areas of the treatment head such that the desired style is achieved regardless of the skill of the user. Embodiments of the apparatus may further include a hinge assembly incorporating one or more ceramic bearings units which provide smooth consistent resistance for pivoting movement of the treatment members and a more durable hinge joint thereby increasing the life and usability of the apparatus. It has been found that conventional hair straighteners and curling irons have certain deficiencies which detract from their usefulness in performing multiple styling functions on a subject’s head. For example, such devices are ill suited to perform the dual function of hair straightening and hair curling. Reasons for this include insufficient heat distribution to the outer heating heads or mandrels, which may be a result of the construction, materials and/or the arrangement and configurations of the heating assemblies of these apparatuses.
Patent NZ-732235-A (NZ)
Title: Dpa-enriched compositions of omega-3 polyunsaturated fatty acids in free acid form
Inventor: MAINES TIMOTHY
IPC: A61K31/202
Filed: 2013-01-04
Abstract: The specification and claims are directed to the composition known in the art as Epanova®. Epanova® comprises eicosapentaenoic acid (“EPA”), in a weight percent amount of 50% to 60%; docosahexaenoic acid (“DHA”) in a weight percent amount of 17% to 23%; and docosapentaenoic acid (n-3) (“DPA”) (clupanodonic acid) in a weight percent amount of 1% to 8%; and wherein at least 90% by weight of the polyunsaturated acid in the composition is present in the free acid form. In a preferred embodiment Epanova® is to be presented in the form of capsule for oral administration of a Type A porcine soft gelatin capsule coated with poly(acrylatemethylmethacrylate) copolymer (Eudragit NE 30-D), and containing one gram of a PUFA composition in which the polyunsaturated fatty acids are present in the form of free fatty acids and contains: 0.55% linoleic acid; 0.15% gamma-linolenic acid; 0.39% alpha-linolenic acid; 1.70% moroctic acid; 0.10% eicosadienoic acid; 0.35% dihomo-gamma-linolenic acid; 2.43% arachidonic acid; 0.15% eicosatrienoic acid; 2.18% eicosatetraenoic acid; 57.25% eicosapentaenoic acid (EPA); 2.79% heneicosapentaenoic acid; 0.83% docosapentaenoic acid; 6.23% docosapentaenoic acid (DPA); and 19.58% docosahexaenoic acid (DHA). Also disclosed is Epanova® for use in the treatment of severe hypertriglyceridemia, wherein the treatment comprises: orally administering the composition to a patient having pre-treatment serum or plasma triglyceride levels ≥500 mg/dL, in an amount and for a duration effective to reduce serum or plasma triglycerides below pre-treatment levels.
Patent NZ-732799-A (NZ)
Title: Picolinamides with fungicidal activity
Inventor: YAO CHENGLIN
IPC: A01N43/40
Filed: 2015-12-21
Abstract: The invention relates to picolinamides of Formula I and their use as fungicides.
Patent NZ-733055-A (NZ)
Title: Anti-c10orf54 antibodies and uses thereof
Inventor: LIPPINCOTT JOHN
IPC: A61K39/395
Filed: 2015-12-11
Abstract: The present disclosure relates generally to anti-C10orf54 antibodies, including antibody-drug conjugates comprising the antibodies, and methods of their use.